text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2021년 09월 30일\n)\n(단위 : 천원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n한국제약협동조합\n-\n-\n단순투자\n50,027\n-\n0.01\n50,027\n-\n-\n-\n-\n0.01\n50,027\n-\n-\n(주)포레스토리\n비상장\n2012.05.22\n경영참여\n310,000\n62,000\n51.67\n46,972\xa0\n-\n-\n-46,972\n62,000\n51.67\n-\n146,259\xa0\n-203,006\xa0\n커넥타젠\n비상장\n2018.02.19\n일반투자\n2,000,000\n400,000\n28.57\n1,008,242\n-\n-\n-57,333\n400,000\n28.57\n950,909\n2,725,090\n162,362\n(주)엑세스바이오\n상장\n2019.07.03\n경영참여\n24,864,499\n9,171,729\n25.26\n35,589,320\n-\n-\n35,563,179\n9,171,729\n25.26\xa0\n71,152,499\n170,184,240\n47,812,194\n(주)인큐텐\n비상장\n2020.12.03\n일반투자\n550,000\n110,000\n39.29\n550,000\n-\n-\n-294,215\n110,000\n39.2\n255,785\n1,375,283\n-68,997\n(주)엔비알\n비상장\n2021.07.30\n일반투자\n3,000,000\n-\n-\n-\n30,000\n3,000,000\n-18,375\n30,000\n33.33\n2,981,625\n88,983\n-2,570\n합 계\n9,743,729\n-\n37,244,561\n30,000\n3,000,000\n35,146,284\n9,773,729\n-\n75,390,845\n-\n-\n* (주)인큐텐은 2020년 12월 03일 지분증권(신규설립)을 취득하였습니다. * (주)엔비알은 2021년 07월 30일 지분증권(유상증자)을 취득하였습니다. \n']"
